HOME >> MEDICINE >> NEWS
Rochester study shows ethnic disparities in medicare claims

African Americans and Latinos are more likely to underestimate how long it has been since their last routine screening test for disease -- such as a mammogram, Pap smear, or cholesterol test according to a University of Rochester study that matched patient recollections with Medicare documentation. Researchers are concerned this might be harming the health of minorities in the long run.

"If you ask anyone, "When was the last time you had a mammogram, or a cholesterol test?' almost all people will think it's been a shorter time than it's actually been. Over-reporting happens to all of us," said lead author Kevin Fiscella, M.D., M.P.H. "But our study found that some minorities tend to over-report even more often than other groups of patients. This is a problem that has to be recognized and fixed."

Fiscella, an associate professor of Family Medicine and Community and Preventive Medicine at the University of Rochester Medical Center, said he is not sure why the discrepancy in reporting exists. One theory supported by social psychology research is that African American or Latino patients may feel some pressure to defy stereotypes. So, when doctors or nurses ask them about an event for which they are uncertain, they err on the side of caution and reply affirmatively, he said.

The study is to be published Sept. 29, 2006, in the open access journal BMC Health Services Research.

The University of Rochester collaborated with colleagues from the University of California in Sacramento to analyze 49,645 patient records, matching Medicare claims with patient surveys of the last preventive screening test they had received. The researchers made statistical adjustments for age, gender, income, education level and health status.

With the exception of PSA testing for prostate cancer, results showed that minority patients were more likely to report taking part in a test in the absence of a submitted Medicare claim. In addition to over-re
'"/>

Contact: Leslie Orr
leslie_orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
29-Sep-2006


Page: 1 2

Related medicine news :

1. Rochester spreads knowledge of cancer-related fatigue
2. Rochester study rolls out RU-486 to treat uterine fibroids
3. University of Rochester spin-off secures $2 million in funding
4. Rochester researchers join federal initiative to improve drug safety
5. Rochester launches Cancer Stem Cell Research Program
6. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. New study shows promise in reducing surgical risks associated with surgical bleeding
9. New study counts the economic cost of persistent pain in Australia
10. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
11. Most seniors now have drug coverage, U-M study shows

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rochester study shows ethnic disparities medicare claims

(Date:4/18/2014)... (April 21, 2014) -- A group of scientists ... and the Sanders-Brown Center on Aging has found ... and neuropsychological function in Parkinson,s disease (PD). ... , the study, which assessed cognitive function in ... the dopamine replacement therapy commonly used to treat ...
(Date:4/18/2014)... memories? How did it make you feel? According to ... experience, such as how sad you were or how ... when you can,t stop thinking about it. , ... context of the memories, rather than how you felt, ... the negative effects of these memories, a new study ...
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
Cached News: